Evidence map›Paper›PMID 24907355›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2014

Generation and characterization of a novel CYP2A13--transgenic mouse model.

Kunzhi Jia, Lei Li, Zhihua Liu, Matthew Hartog, Kerri Kluetzman, Qing-Yu Zhang, Xinxin Ding

Open access · bronzeAbstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.9field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Assessing cytochrome P450 function using genetically engineered mouse models.Advances in pharmacology (San Diego, Calif.) · 2022
    Review
  3. Toxins · 2021
    Article
  4. Genetic and Enzymatic Characteristics of CYP2A13 in Relation to Lung Damage.International journal of molecular sciences · 2021
    Review
  5. Article
  6. Article
  7. P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.Drug metabolism and disposition: the biological fate of chemicals · 2018
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Kunzhi JiaWadsworth Center, New York State Department of Health, and School of Public Health, State University of New York, Albany, New York.
Lei LiWadsworth Center, New York State Department of Health, and School of Public Health, State University of New York, Albany, New York.
Zhihua LiuWadsworth Center, New York State Department of Health, and School of Public Health, State University of New York, Albany, New York.
Matthew HartogWadsworth Center, New York State Department of Health, and School of Public Health, State University of New York, Albany, New York.
Kerri KluetzmanWadsworth Center, New York State Department of Health, and School of Public Health, State University of New York, Albany, New York.
Qing-Yu ZhangWadsworth Center, New York State Department of Health, and School of Public Health, State University of New York, Albany, New York.
Xinxin DingWadsworth Center, New York State Department of Health, and School of Public Health, State University of New York, Albany, New York xding@albany.edu.
New York State Department of Health · USUniversity at Albany, State University of New York · USWadsworth Center · US

Funding

Human CYP2A and respiratory tract xenobiotic toxicityR01CA092596 · NCI · WADSWORTH CENTER · PI DING, XINXIN · 2003 to 2020
$6.1M
P450-Mediated Dehydrogenation MechanismsR01GM074249 · NIGMS · UNIVERSITY OF UTAH · PI REILLY, CHRISTOPHER A · 2006 to 2014
$2.4M
NCI NIH HHS CA092596NCI NIH HHS R01 CA092596NIGMS NIH HHS GM074249NIGMS NIH HHS R01 GM074249
6 · The paper itself

Abstract

CYP2A13, CYP2B6, and CYP2F1 are neighboring cytochrome P450 genes on human chromosome 19, and the enzymes that they encode overlap in substrate specificity. A CYP2A13/2B6/2F1-transgenic mouse, in which CYP2A13 and 2F1 are both expressed in the respiratory tract and CYP2B6 is expressed in the liver, was recently generated. We generated a CYP2A13 (only) transgenic mouse so that the specific activity of CYP2A13 can be determined. The CYP2B6 and CYP2F1 genes in the CYP2A13/2B6/2F1 genomic clone were inactivated via genetic manipulations, and CYP2A13 was kept intact. A CYP2A13 (only) transgenic (2A13-TG) mouse was generated using the engineered construct and then characterized to confirm transgene integrity and determine copy numbers. The 2A13-TG mice were normal in gross morphology, development, and fertility. As in the CYP2A13/2B6/2F1-transgenic mouse, CYP2A13 expression in the 2A13-TG mouse was limited to the respiratory tract; in contrast, CYP2B6 and 2F1 proteins were not detected. Additional studies using the CYP2A13-humanized (2A13-TG/Cyp2abfgs-null) mouse produced by intercrossing between 2A13-TG and Cyp2abfgs-null mice confirmed that the transgenic CYP2A13 is active in the bioactivation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a lung procarcinogen. The 2A13-TG mouse should be valuable for assessing specific roles of human CYP2A13 in xenobiotic toxicity in the respiratory tract.

Indexed as

AnimalsAryl Hydrocarbon HydroxylasesDisease Models, AnimalGene DosageHumansMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicRespiratory SystemAryl Hydrocarbon HydroxylasesCYP2A13 protein, human

Identifiers

PMID24907355
PMCPMC4109209
OpenAlexW2154178396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.